Our History and Heritage

LEO Pharma’s core values - Integrity, Customer focus, Innovation, Passion and Adaptability - have been at the heart of LEO Pharma since our founding in Denmark over a century ago. By translating these values into reality, LEO Pharma has developed into a world leader in dermatology (skin) and thrombosis (blood clots) through the development of innovative treatments and patient-focused offerings to improve the lives of millions around the world. 

In 1908 two pharmacists, August Kongsted and Anton Antons, purchased a pharmacy in Copenhagen, Denmark, naming it ‘Københavns Løveapoteks kemiske Fabrik’. Later changing the name to LEO Pharma, Kongsted and Anton’s pharmacy grew from humble beginnings to the global organisation that it is today.

 
Following early successes in innovative medical production across a wide range of therapeutic areas between the 1930s and 1940s, LEO Pharma began to focus on improving the lives of people living with dermatology (skin) and thrombotic (blood clot) conditions from the mid-1940s onwards. Today, LEO Pharma employs over 5,000 colleagues helping people around the world enjoy a healthier and greater quality of life.

LEO Pharma started to expand outside of Scandinavia during the 1950s and 1960s and the LEO Pharma logo was first registered in 1956.

The Company established its UK presence in 1960, with a focus on improving patient quality of life and medical education programmes. This focus continues today, from our modern Berkshire offices.

In 1959, LEO Pharma’s commercial organisation in Ireland was set up as well as the manufacturing site in Dublin, Ireland. Development continued throughout the 1970s and 1980s and a topical dermatological plant was completed in 1992. Enhancements to the Dublin site, including further expansion of the topical dermatological plant, have continued since, with a new sterile facility being completed in 2008. Elsewhere in Ireland, a heparin purification plant in Cork was built in 1987, which continues to play a key role in production.

LEO Pharma UK and LEO Pharma Ireland united as a joint LEO Pharma UK/IE commercial affiliate in 2012. Since January 2017 the LEO Pharma UK/IE affiliate also acts as the central international hub coordinating activities for the ‘Region Europe North+’ cluster of LEO affiliates. In addition to the UK and Ireland the cluster comprises of Norway, Denmark, Sweden, Finland, Australia and New Zealand.

Further information about LEO Pharma’s history can be found on our global website.

Cookies on this site

LEO Laboratories Limited uses cookies to give you the best experience online and to provide anonymised, aggregated site usage data. You can find out what cookies we use, what they do and how you can disable them in our Cookie Policy. By browsing our sites, you consent to the use of cookies. If you want to know more about our cookie policy and how to avoid and delete cookies click here. By continuing to browse this site, you consent to our use of cookies on this device in accordance with our cookie policy unless you have disabled them.